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cDepartment of Surgery, Vancouver Island Health Authority, Royal Jubilee Hospital, Victoria, British Columbia, CanadaAbstractPurpose: The Radiology Department, Royal Jubilee Hospital, Victoria, BC, with the support of gastroenterologists and surgeons, was
awarded a BC Innovation fund to run a pilot project of computed tomographic colonography to reduce an unacceptably long 2-year
colonoscopy waiting list. Funds were approved in April 2007 for a 1-year project, which was completed on March 31, 2008.
Methods: This article describes the challenges of delivering a high-volume computed tomographic colonography program at a busy
community hospital, with discussion of the results for the 2,005 patients who were examined.
Results: Colonoscopy was avoided in 1,462 patients whose computed tomographic studies showed no significant lesions. In the remainder of
patients, only lesions larger than 5 mm were reported, with a total of 508 lesions identified in 433 patients. There were 57 cancers of which 52
were reported as either definite or possible cancers, whereas 5 were not seen on initial scans. Some of the patients with cancer had been on the
colonoscopy waiting list for 2 years. In addition, there were 461 patients with significant extracolonic findings, including 84 who required
urgent or semi-urgent further management for previously unsuspected conditions, such as pneumonia, aneurysms larger than 5 cm, and
a range of solid renal, hepatic, and pancreatic masses. There were no procedural complications from the computed tomographic colon studies.
Conclusions: We have shown that it is feasible to run a high volume CTC service in a general hospital given hospital support and funding.
The benefits in this group of over 2000 patients included avoidance of colonoscopy in over 70% of patients, detection of significant polyps or
cancer in approximately 20% of patients, and identification of clinically important conditions in 7%e18% depending on the definition used.
The estimated costs including capital, operating, and professional fees were in the range of $400.Re´sume´Objet: Le de´partement de radiologie, de l’hoˆpital Royal Jubilee de Victoria, en accord avec les e´quipes de gastroente´rologie et de chirurgie,
graˆce au support financier de fonds provinciaux d’aide a` l’innovation, a re´alise´ un projet pilote visant a` utiliser la colonoscopie virtuelle ou
coloscanner afin de re´duire le temps d’attente inacceptable de 2 ans sur liste de colonoscopie. Le projet d’une dure´e de 1 an a de´bute´ a`
l’arrive´e des fonds en avril 2007 pour s’achever le 31 mars 2008.
Me´thodes: L’objectif du propos porte sur la faisabilite´ de la mise en place d’une activite´ a` de´bit e´leve´ de coloscanner au sein d’une structure
hospitalie`re ge´ne´rale et sur les re´sultats des 2 005 patients qui ont be´ne´ficie´ de l’examen.
Re´sultats: 1462 patients n’ont pas be´ne´ficie´ d’une colonoscopie en raison d’un coloscanner ne pre´sentant pas de le´sion significative. Seule
les le´sions de plus de 5 mm ont e´te´ de´crites avec un total de 508 le´sions de´tecte´es chez 433 patients. Parmi les 57 cancers colorectaux, 52
avaient e´te´ affirme´s ou suspecte´s en colonoscopie virtuelle tandis que 5 n’avaient pas e´te´ de´tecte´s sur le scanner initial. Parmi les patients
pre´sentant un ne´oplasie colorectal, certains figuraient sur la liste d’attente pour une colonoscopie depuis deux ans. Par ailleurs, le coloscanner
a permis de de´couvrir chez 461 patients des anomalies extra coliques qui dans 84 cas ont ne´cessite´ une prise en charge urgente ou semi
urgente devant la de´couverte fortuite de pathologies telle que des pneumonies, des ane´vrismes de l’aorte abdominale de plus de 5 cm, des
masses solides re´nales, des masses he´patiques ou pancre´atiques. Il n’a pas e´te´ observe´ de complication imme´diate ou au de´cours des
coloscanners.* Address for correspondence: John Mathieson, FRCPC, Chief of Radiology, Royal Jubilee Hospital, 1952 Bay Street, Victoria, British Columbia V8R 1J8,
Canada.
E-mail address: john.mathieson@viha.ca (J. Mathieson).
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34 C. Behrens et al. / Canadian Association of Radiologists Journal 61 (2010) 33e40Conclusions: Nous avons prouve´ qu’il est faisable pour fonctionner un service de CTC de grand volume dans un hoˆpital ge´ne´ral donne´
l’appui et le placement de d’hoˆpital. Dans notre groupe de plus de 2000 clients, les avantages comportent d’e´viter coloscopie dans plus de
70%, de´tection des polypes ou du cancer dans environ 20%, et identification des conditions me´dicalement importantes dans 7% a` 18% selon
la de´finition employe´. Les couˆts estimatifs comprenant capital, les frais d’exploitation et les honoraires professionnels e´taient environ $400.
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Computed tomographic colonography (CTC) was inven- by the technologist by examining scout views. Scans were
ted in 1993 and has been evolving over the past 15 years [1].
Recent specialist center and multicenter trials demonstrated
that CTC sensitivity for detection of advanced adenomas is
equal to that of colonoscopy, and its sensitivity for cancer
can exceed that of colonoscopy [2e4]. This superior accu-
racy and improved patient acceptance led many departments
to replace barium enemas with CTC. An opportunity to help
shorten an overly long optical colonoscopy waiting list
provided the impetus to obtain funding to create a high-
volume CTC service in Victoria.
We began the CTC service with patients drawn from the
barium enema waiting list and then expanded to include
patients waiting for optical colonoscopy as we developed the
tools and training to handle up to 20 patients per day. By
March 31, 2008, when the project terminated, we had exam-
ined 2,005 patients. Over the next few months, follow-up data
were collected on colonoscopy and pathology findings.
Since April 2008, the CTC service has continued without
specific funding at about 15 patients a day, divided between 2
hospitals in Victoria. Two formal CTC training workshops
were held, and all the hospitals on Vancouver Island have been
equipped with appropriate 3-dimensional (3D) CTC work-
stations networked to permit collaboration and consultation.MethodsEquipmentAlthough it is clear that early generation multislice scan-
ners can produce acceptable CTC images, we were fortunate
in having 64-row scanners available because the examination
is a little quicker and the images are sharper. Buscopan
(Boehringer Ingelheim GmbH, Ingelheim, Germany) was not
used initially, but, after evaluation in the first part of the study,
it was then routinely used, given as 20 mgm intravenous
before starting insufflation. For the rare patient with an
absolute contraindication to the use of Buscopan, scans were
performed either without an antispasmodic or with glucagon
1 mgm intravenous.Scan ProtocolA small flexible rubber catheter was inserted per rectum,
and the colon was distended with carbon dioxide by using
a pressure-controlled pump (E-Z-EM Protoco2l; E-Z-EM,
Lake Success, NY). Adequate colon distension was confirmedacquired on one of two 64-channel computed tomography
(CT) scanners: Sensation 64 (Siemens AG Healthcare,
Erlangen, Germany) or Aquilion 64 (Toshiba Medical
Systems, Tochigi-ken, Japan). Image data were acquired at
the smallest available collimation (0.625 or 0.5 mm), with
a reconstruction interval of 1 mm by using 120 kVp and 50
mA. Scans were obtained in the supine position for all patients
and also either in the prone or decubitus positions. In some
patients in whom adequate distension was not obtained in the
first 2 scanning positions, a third sequence was obtained.
Image processing and interpretation was performed by
using a Viatronix V3D Colon workstation (Viatronix Inc.,
Stony Brook, NY). Image interpretation was made primarily
by using 3D images, with secondary use of 2-dimensional
(2D) images. We selected a Viatronix workstation by taking
advantage of its then unique ability to provide rapid visual
confirmation of attenuation values during 3D fly-through
assessment to identify at a glance whether a protuberance was
soft tissue (polyp or cancer, although it cannot distinguish
between these 2), rather than stool with tagging, lipoma, or
mucus. A standard reading included 4 fly-throughs of the
colon in 3D: 1 each way on supine and prone images, with 2D
imaging for problem solving, and a final 2D examination of
the noncolonic structures in the abdomen and pelvis.Bowel PreparationIt became apparent very quickly that, without fecal
tagging, there would be an unacceptably high rate of false-
positive reports for smaller- and medium-sized polyps [5,6].
A combination of barium sulfate and water-soluble contrast
was used, together with the purgatives PICO-SALAX (Fer-
ring Pharmaceuticals, Saint-Prex, Switzerland) and Dulcolax
(Boehringer Ingelheim GmbH). This combination worked
moderately well, but a substantial minority (about 20%) of
patients had a sticky coat of barium adherent to the colon-
ic mucosa in places that interfered with visualization.
Modifications to the preparation, including reduction in
tagging-agent volumes and changes in the timing of the
administration of purgatives, were successful in eliminating
the sticky coat problem [7].Radiologist TrainingThree radiologists were trained before the project began.
They were joined over the ensuing months by 9 others who
attended workshops run by Pickhardt et al [4].
Table 1
35CTC to reduce colonoscopy wait time / Canadian Association of Radiologists Journal 61 (2010) 33e40Carbon Dioxide Insufflations
Indications for computed tomographic colonoscopy
Group Subgroup Number (%) Number (%)
Screening No family Hx 509 (25.4) 984 (49.1)
Family Hx of polyp/CRCA 475 (23.7)
Surveillance Previous polyp Hx 112 (5.6) 148 (7.4)
Previous CRCA Hx 36 (1.8)
Symptomatic Abdominal mass 10 (0.5) 873 (43.5)
Blood PR/þfobt 421 (21.0)
Weight loss 40 (2.0)
Change in BM 287 (14.3)
Abdominal pain 115 (5.7)
Total 2,005
Hx ¼ history; CRCA ¼ colorectal carcinoma; PR ¼ per rectum; fobt ¼ fecal
occult blood test; BM ¼ bowel movement.Several studies showed that, in patients having colono-
scopy or barium enema, postprocedural pain is caused by
nitrogen retention associated with the use of room air,
whereas, with carbon dioxide, there is no postprocedural pain
[8,9]. In CTC, the 18 cases of perforation reported all
occurred with staff-administered insufflation of room air
[10,11], and, so far, there are no reports of perforation from
automated insufflations of carbon dioxide. Carbon dioxide is
rapidly absorbed, which makes it important to leave the
insufflation machine turned on until the end of the exami-
nation so that gas is replenished and keeping the colon dis-
tended for both the supine and prone series. We are
concerned that the lower rectum and anal canal may be
obscured by the catheter tip and retention balloon [12,13],
but it is not clear whether the enema tip can routinely be
removed immediately before the final prone series without
loss of distension.BuscopanEarly on in the project, several cases of inadequate
distension were noted. The literature was ambivalent about
the role of intravenously administered Buscopan [14e17].
Our own study showed that its use was associated with
improved distension, with an odds ratio of 7.8 of achieving
optimal distension [18]. This was especially true in the
presence of diverticular disease. Having confirmed its
effectiveness, we avoided major delays in drug administra-
tion by using trained technologists [19] rather than nurses to
inject Buscopan just before insertion of the enema tip. As an
additional bonus, technologists noted that patients seemed
more comfortable, and the time to full distension was
reduced.ReferralsTable 2
Lesions seen on computed tomographic colonoscopy
Finding No. lesions No. patients
Lipoma 14 12
Polyp 6e9 mm 226 180
10e19 mm 139 121
20þ mm 36 32
Total 401 333
Polyp (equivocal) 6e9 mm 3 3
10e19 mm 11 11
20þ mm 7 7
Total 21 21
Cancer 40 37
Cancer (equivocal) 32 30Referrals from colonoscopists were solicited, with no
restriction on whom the colonoscopists chose to refer. In
general, they referred patients who had been on the waiting
list the longest time. Most were screening and surveillance
patients as well as the lower-risk symptomatic ones. On
review of the indications, many of the screening and
surveillance patients also had minor symptoms. Symptomatic
patients were also accepted from family physicians because
they could obtain a CTC more quickly than a gastroenter-
ology consult.
Patients whose colonoscopies were incomplete were also
accepted at first, until it became apparent that, without fecal
tagging, there was an unacceptably high false-positive rate
because of difficulty in distinguishing between stool and
polyp, because stool does not always have the characteristic
inhomogeneity. Our current bowel preparation with fecal
tagging is acceptable to both colonoscopists and CT radiol-
ogists so that, if necessary, the 2 tests can be done on the
same day in either order.ResultsPatient PopulationOur study population included 2005 patients, with a mean
age of 62 years and range of 22e94 years. The sex distri-
bution was 59.6% women and 40.4% men. Approximately
half of the patients were for screening and half were symp-
tomatic, with only a few for surveillance, as shown in
Table 1.FindingsThe lesions seen and reported on CT are summarized in
Table 2 (see Follow-up Colon Investigations section for
colonoscopy and pathology results for lesions that were
investigated further).Equivocal Reports AnalysisOn a review of the 2,005 reports, there were 53 lesions in
50 patients in whom the findings were equivocal (possible
mass, minor bowel-wall thickening, slight bowel-wall
thickening because of stool or a lesion, a polyp cannot
confidently be excluded) often associated with inadequate
distension. The images from these cases were reviewed by
experienced radiologists without knowledge of the follow-up
Table 3
Results of review of equivocal computed tomographic reports
Final findings
Radiologic opinion on
review of images
Normal
Equivocal, needs
colonoscopy
Definite
diagnosis
Failed
examination
Diverticular
disease
5
Cancer 2 4a
Polyp 1b 5
Other 1 SRUS 1 leiomyoma (GIST)
Normal
colonoscopy
12 7 2
No follow-up 5 3 1
Failed
colonoscopy
1
GIST ¼ gastrointestinal stromal tumour; SRUS ¼ solitary rectal ulcer
syndrome.
aThree confirmed, 1 ‘‘hard, thick, scarred fold’’ with negative biopsy.
bA 6-mm serrated adenoma.
Table 4
Recommendations from computed tomographic colonoscopy (CTC) for
further colon investigations
Investigation Indication No. Total
None required d 1,462 1,462
Colonoscopy Suspected colonic
neoplasms (polyp, cancer)
351 515
Small-bowel polyp 1
Diverticular disease 17
Other colonic lesion 1
Colitis 2
Inadequate view,
inadequate colonic distension
140
Inadequate view,
artifact from hip prosthesis
3
Repeated CTC Need higher
radiation dose because
of obesity
1 28
Inadequate bowel preparation 27
Total 2,005
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equivocal needing colonoscopy, definite diagnosis, or failed
examination and needs to be repeated. These allocations and
the final diagnoses are shown in Table 3.
Among the equivocal cases, there were 5 definite diag-
noses possible on radiologic review, 4 were subsequently
confirmed. Of the 24 still found to be equivocal on review, 13
had abnormalities on colonoscopy, including 2 cancers, and
11 had no lesion found, 7 of these with normal colonoscopy.
Among those thought to be normal on review, 13 had colo-
noscopy and 12 were indeed normal. These 50 cases with
equivocal reports are thus a high-risk group, including
5 cancers and a leiomyoma (gastrointestinal stromal tumour),
deserving of further review by an expert panel, perhaps as
part of routine department policy.Follow-up Colon InvestigationsThe follow-up colon investigations recommended after
CTC for all 2,005 patients in the study are summarized in
Table 4. Perhaps the most important finding is that, of the
2,005 patients examined, 1,462 did not require a colonoscopy
and were removed from the waiting list. To assess the
performance of the first year of CTC at our institution,
surgical and pathology reports were obtained for all patients
in this study who had colonoscopy. Most of the colonos-
copies in this series were performed as a result of an
abnormal CTC, but, in a few cases, the CTC was carried out
as a result of an incomplete colonoscopy. In the latter cases,
the colonoscopy reports were reviewed for CT false-positive
analysis: if a lesion reported on CT was not seen in an
adequately visualized region during the preceding colono-
scopy, then the lesion was presumed to be a false positive. A
summary of patients that were investigated via direct
methods (endoscopy or laparotomy) and their indications
based on CTC findings are summarized in Table 5.The findings in the 382 patients who had colonoscopy
and/or laparotomy were compared with the findings seen on
CTC. The histologic type of all biopsied lesions was noted
when it was available. The size of each lesion was recorded
by using information in the following order of preference
(when available): pathology, direct examination, and CT
measurement. A lesion seen on CTC was called a true
positive when a lesion of similar size and location was noted
on direct examination, regardless of the histology of the
lesion. A lesion seen on CT that was not seen on direct
examination was called a false positive. A lesion larger than
5 mm found on direct examination that was not noted on CT
was called a false negative. A summary of lesions seen on
direct examination and lesions seen on CT that were subject
to direct examination is found in Table 6. Lesions in this
table include all that were suspicious for polyp, cancer, or
other unknown mass.
In computing the numbers of CTC true and false positives
and false negatives, we assumed that colonoscopy was
perfect. In reality, studies have documented a false-negative
rate of approximately 10% at optical colonoscopy, but we do
not yet have adequately detailed follow-up to calculate that
rate for our study. We are aware of at least 1 large (20-mm)
intramural leiomyoma (gastrointestinal stromal tumour) and
1 ascending colon cancer that were missed on optical
colonoscopy.
A total of 430 definite or equivocal lesions seen on CT
were investigated via direct examination and 327 (76.0%) of
these were found to be true positives (Table 6). Of the 387
definite calls, 305 (78.8%) were true positives. Of the 43
equivocal calls, 22 (51.1%) were true positives . From direct
examination of 382 patients in the study, 362 lesions were
found, and 35 (9.7%) of these were found to be false nega-
tives. The histologic type for all 362 lesions found on direct
examination and how these lesions were called on CTC are
shown in Table 7.
We examined in detail the 5 patients in whom CTC did
not initially detect carcinoma. Two of these were low rectal
Table 6
Summary of lesions seen on computed tomography vs direct examination
Lesion
on OC/lap
No lesion
on OC % true positive
Lesion on CT 6e9 mm 148 43 77.5
10e19 mm 94 32 74.6
20þ mm 63 7 90.0
Equivocal
lesion on CT
6e9 mm 3 1 75.0
10e19 mm 4 9 31.8
20þ mm 15 11 57.7
Total 327 103 76.0
Lesion on OC/lap
No lesion on CT 6e9 mm 19
10e19 mm 10
20þ mm 6
Total 35
CT ¼ computed tomography; OC ¼ optical colonoscopy; lap ¼ laparotomy,
76.0% overall true positive.
Table 5
Patients who had computed tomographic colonoscopy and who had colo-
noscopy or laparotomy
CT result CT detail
Not
investigated
Partially
investigateda
Fully
investigated Total
CT positive Mass lesion 48 5 300 353
Other lesion 2 0 0 2
CT
indeterminate
Inadequate
view
129 0 15 144
Inadequate
preparation
23 0 4 27
DDb 13 0 4 17
CT negative 1,408 0 54 1,462
Total 1,623 5 377 2,005
CT ¼ computed tomography; DD ¼ diverticular disease.
aPatients with multiple lesions, some were visualized and others were not
(eg, because of incomplete colonoscopy or surgical resection of only one
affected region).
bVery severe DD, impairing complete evaluation.
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perhaps because it was a flat lesion further compressed by the
retention balloon catheter. A third was a 10-mm sigmoid
polyp that contained a focus of adenocarcinoma. The lesion
was not well seen, even on review, because of diverticular
disease and retained feces. The remaining 2 were ascending
colon lesions that showed poor bowel preparation and poor
distention. One of these patients had a repeated CTC, with
a better cleansing, and the lesion was then seen. We noted
that, other than a young patient with a compressed anorectal
carcinoma, the mean age of the other 4 patients with missed
cancers was 80 years. Extra attention to 2D images of the
rectum and cecum in elderly patients with retained feces and
poor distension should reduce this error rate.Extracolonic FindingsWe reported 2493 extra colonic findings in our 2005
patients, most of which were described as incidental and
requiring no further workup. In 175 (7%), further investi-
gation was recommended, including 60 semi-urgently (for
example for solid renal, pancreatic or liver masses) and 24
urgently (4 pneumonia; 3 large, >5 cm aortic aneurysms;
and 17 pleural or pericardial effusions). There were, in
addition, 139 with renal calculi, 115 with gallstones, 198
with hernias of various types (32 nonhiatal), and 868 with
various musculoskeletal abnormalities, mainly lumbar facet
joint and degenerative disc disease. Including those with
gallstones, renal calculi and nonhiatal hernias significant
extracolonic findings were described in 461 or 18%.
Discussion
In addition to the importance of earlier detection of more
than 50 colon cancers and several hundred significant polyps
as well as critical extracolonic pathologies, the major impact
for the 2005 patients examined by CTC is that 1462 had
a normal examination and thus no longer occupied slots onthe colonoscopy waiting list, depriving patients with disease
of the opportunity of early diagnosis. As CTC becomes
routinely available in all hospitals, endoscopists and radiol-
ogists will need to establish clinical guidelines to triage
patients to a colonoscopy or CTC [2]. One example of
a possible distribution, though the exact dividing point will
vary from hospital to hospital, depending on availability of
the different resources, and local expertise is shown in
Table 8.
In general, there is little point in allowing patients with
probable inflammatory bowel disease to have CTC.
However, there is no point in allowing low-risk patients to
wait for colonoscopy when CTC can select out the 80%
without significant polyps. A recent review of CTC as
a screening tool concluded that it would be less cost effective
than colonoscopy, unless the cost could be reduced below
CD$662 per patient [20,21]. A realistic goal of $400 per
patient would render primary CTC screening a very cost-
effective method of screening. Furthermore, the colonoscopy
waiting lists are so long that CTC has a great dealt to offer in
preventing patients with early cancer from progressing to
incurable disease while waiting for their colonoscopy.
Although a system is proposed (see Table 8) to triage
patients to either CTC or colonoscopy, some patients will
have to undergo both examinations. CTC for screening will
be more readily accepted if we ensure that therapeutic
colonoscopy can occur on the same day as a positive CTC
examination so that patients only have to endure 1 bowel
preparation. Conversely, for patients triaged to colonoscopy,
the option of having same-day CTC in the event of incom-
plete colonoscopy may reduce heroic efforts to reach the
cecum in difficult cases, resulting in less patient discomfort
and lower risk of perforation. Whether CTC is to follow
colonoscopy or vice versa, a common bowel preparation
regime is required that does not interfere with visualization
during colonoscopy and includes fecal tagging to avoid false
positives on CTC. During this project, we experimented with
different bowel preparation regimes and currently have 1 that
is satisfactory for both CTC and colonoscopy [7].
Table 7
Histologic type of lesions found on direct examination and how they were
called on computed tomography (CT)
Histologic
type
How lesions were called on CT
Polyp Cancer
Equivocal,
polyp
Equivocal,
cancer Lipoma Missed Total
Other benign 22 2 2 9 0 0 35
Not analyseda 10 0 0 0 5 0 15
Hyperplastic 20 0 1 0 0 2 23
Juvenile 1 0 0 0 0 0 1
Serrated 11 0 1 0 0 1 13
Tubular,
<10 mm
80 0 1 0 0 12 93
Tubular,
10þ mm
43 0 1 0 0 9 53
Tubulovillous 54 1 1 0 0 5 61
Villous 2 1 1 0 0 0 4
High-grade
dysplasia
4 1 1 0 0 1 7
Carcinoma 18 30 0 4 0 5 57
Total 265 35 9 13 5 35 362
aNo pathology available because of unretrieved or insufficient tissue.
Table 8
Potential patient allocations to computed tomographic colonoscopy (CTC)
and colonoscopy
CTC Colonoscopy
Incomplete colonoscopy þþ
Screening normal risk þþ
Screening mild
family history
þþ
Minor lower-GI symptoms þþ
Surveillance þþ
Positive guaiac þþ þ/e
Positive iFOBT þ/e þ/e
Major bowel symptoms þ/e þþ
HNPCC þþ
Highly probable neoplasm þþ
Cancer for biopsy þþ
Acute lower-GI
bleed (or CT angiogram)
þþ
Suspect IBD þþ
Diarrhoea þþ
GI ¼ gastrointestinal; iFOBT ¼ immunochemical fecal occult blood test;
HNPCC ¼ hereditary non-polyposis colorectal cancer; IBD ¼ inflammatory
bowel disease.
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has finished, the publicity engendered has increased the CTC
waiting list to 6 months. Each year, 5,000 colonoscopies and
1,500 flexible sigmoidoscopies are performed in Victoria.
We estimate that, if CTC is to play a role in reducing the
colonoscopy waiting list, then there will be a need for in
excess of 3,500 CTC examinations a year. Primary CTC
screening in a center the size of greater Victoria (approxi-
mately 300,000) at ages 55 and 65 years, would require
7,500 CTC examinations a year with 100% patient partici-
pation or, more realistically, 5,000 examinations with 66%
uptake. Large population colon cancer screening should
consider the example of screening mammography programs,
in which free-standing centers outside hospitals were set up
to facilitate greater efficiency and reduced cost as well as
greater patient acceptance. We think that outpatient CTC
clinics in all major population centers will be a more efficient
and cost-effective way to handle the case load rather than
trying to push a large volume of relatively healthy outpa-
tients through an already full hospital CT service.
Despite the high demand for CTC, funding is lacking.
There is no technical fee or professional fee in place for CTC
other than in Quebec. Simply replacing the barium enema
service with CTC will be difficult enough in the present
economic times, and to take on the numbers required to
reduce colonoscopy waiting lists or provide screening will
simply not be possible without increased funding.ErrorsThe overall results from our initial start-up year were not
as good as those from experienced specialist centers. The
specificity of our diagnoses of polyps was 79% (305 of 387
polyps reported were confirmed). It was our deliberate policy
to encourage overcalling during this start-up year tominimize false negatives, and this also led to more equivocal
reports. Advanced adenomas are defined as those adenomas
more than 9 mm in diameter and, in addition, any adenomas
with at least 25% villous component or that contained high-
grade dysplasia. We detected 110 of 125 advanced adenomas
in our patient population, achieving a sensitivity of 88%.
Fifty-two of 57 cancers were detected, and 4 of the misses
were because of perceptive error, because the lesions were
visible in retrospect. Radiologist experience clearly played
a role, because 4 of the 5 missed cancers occurred in the first
half of the study, and the 1 in the second half was missed by
a recently trained radiologist. Mistakes in radiology report-
ing are most commonly because of perceptive errors [22,23],
with technical problems often contributing. We expect that
our detection rate will improve as radiologists become more
experienced and that false positives should decrease with the
routine use of Buscopan, fecal tagging, and double reading of
equivocal cases.
In our series of 2,005 patients, there were 50 cases in
which the radiologist had difficulty determining whether the
study was normal or abnormal, and issued an equivocal
report. These cases constitute a high-risk group that deserve
of further evaluation; they included 5 cancers, 6 polyps larger
than 5 mm, 5 complex diverticular disease, a leiomyoma
(GIST), and 1 solitary rectal ulcer syndrome. Moreover,
expert review of the cases before consulting colonoscopy or
pathology findings allowed 18 of the 50 to be called normal
(Table 3), and, on follow-up, no lesions larger than 6 mm
were seen. Possible solutions to these issues would be to have
nurses or technologists routinely do the initial reading so that
the patient can be referred to same-day colonoscopy if
appropriate. In addition, a system should be developed to
ensure that any equivocal report is flagged and subject to
a departmental review. One way to achieve the latter would be
a standardized reporting system such that radiologists have to
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legitimate choice) that they are unable to categorize the case
with confidence, thus triggering the review by colleagues.
Double reading has been documented to improve detec-
tion of abnormalities in barium enemas [22], mammography
[24], and CTC [25,26]. It does not matter who the second
readers are, so long as they are well trained. It is often not
practical to have examinations read by 2 radiologists, but it is
practical to have the technologist [24,25] or a nurse [26] (C.
D. Johnson, personal communication, 2007) do the initial
reading. Once the possible abnormality has been perceived, it
can be assessed. In Canada, it is not common at present to
have the technologist perform the initial reading, but this
may become critical in centers where same-day colonoscopy
is to be offered when CTC shows significant polyps or
cancer.
Computer-aided diagnosis programs are evolving rapidly.
It may be possible to have the initial read carried out by one
of these software programs at the time of the examination, to
alert the radiologist at once to those patients with significant
lesions who may benefit from same-day colonoscopy.
Currently available systems have not yet reached this stage
[27].
Concern has been expressed about the ability of CTC to
detect serrated adenomas, not only because they may pose
a high risk for malignant development but also they tend to
be flatter than tubular adenomas. It is reassuring, therefore,
that CTC detected 12 of 13 serrated adenomas in our
patients, missing only 1 that was 8 mm in diameter. Most
advanced adenomas are larger than 10 mm in diameter. We
found 6 adenomas with high-grade dysplasia, of which 2
were smaller than 10 mm and the others were 10, 20, 23, and
30 mm. Only 13 of 125 advanced adenomas were smaller
than 10 mm.Extracolonic FindingsThe finding of extracolonic abnormalities is a bonus of
CTC but one that may lead to additional morbidity from
investigation of silent abnormalities that are of no clinical
importance. We found that 7% of our study population
required further investigations and up to 18% if one chose to
include all gallstones, renal stones, and nonhiatal hernias. In
the American College of Radiology Information Network
(ACRIN) study, abnormalities that required further evalua-
tion were found in 16% [3]. Chin et al [28] found clinically
significant lesions in 7.4%, at a per-patient increased cost of
$24 or 14%, although they noted that limiting reporting of
extracolonic abnormalities to the aorta and kidneys would
have reduced the number of subjects that required follow-up
to 3% and the cost increase to 4.7%, without detriment to the
clinical outcome. Gluecker [29] found the increased cost of
extracolonic findings to be 6% or $34. There is, at present,
no general agreement on a policy on reporting of extrac-
olonic abnormalities. Chin et al [28] described the additional
burden of follow-up of these findings as modest and suggests
that they could be reduced further if clear clinical andradiologic criteria are developed to guide further investiga-
tion. These would need to be explicitly described in the CTC
report.
Tolan [30] brings a different perspective to this issue; in
an article on barium enema replacement by CTC in the
symptomatic elderly, a very different group from a screening
population. In 400 sick elderly patients, they found 23 non-
colonic malignancies and previously unknown significant
abnormalities in 24% of patients. Hara [31] found significant
abnormalities in only 5% of a screening population. The
conclusion of Tolan [30] is that the importance of the
numerous noncolonic findings in elderly symptomatic
patients makes a compelling case for substituting barium
enema with CTC. Different reporting policies may be
required for reporting CTC in elderly symptomatic patients
compared with a screening program, to minimize the follow-
up of insignificant lesions in a screening population.
This, in turn, raises the issue of whether CTC in the
elderly patients, especially in symptomatic patients should
only be performed with intravenous contrast enhancement, as
suggested by Spreng [32]. We did not use contrast
enhancement for any of our studies. A case can be made that,
when CTC shows a carcinoma, a staging scan should be done
at the same visit with contrast and with higher amperage.
This will require the technologist to do an immediate reading
and discuss with the radiologist the addition of the contrast
study.
The CT Colonography Reporting and Data System
(C-RADS) reporting system [33] offers 1 suggestion for
allocating extracolonic lesions to a category that dictates
whether follow-up is required, depending on local agreement
among radiologists, surgeons, and gastroenterologists in
a community. Alternatively, a more detailed model may be
recommended by a national or provincial body but would
still require local approval.ConclusionOur 1-year project to reduce the optical colonoscopy
waiting list produced positive health outcomes with earlier
detection of more than 50 cancers and more than 100
advanced adenomas whose removal has prevented many
future cancers. In addition, the diversion of hundreds of
patients from the colonoscopy list shortened the wait for
other patients. Finally, clinically important unsuspected
finding were detected in from 7%e18% of patients,
depending on how clinical importance is defined.
We showed that it is feasible to train staff and to run
a high-volume CTC service in a general hospital, given
hospital support and funding. Initial concerns about adding
up to 20 patients a day to the workload of a busy department
with 2 scanners that were already fully booked were over-
come by enthusiastic staff and funding of increased hours
from the Innovation fund. Buscopan, carbon dioxide, and
fecal tagging were essential technical components of the
examination, as was a workstation that provided quality
images in 2D and 3D with rapid visual display of attenuation
40 C. Behrens et al. / Canadian Association of Radiologists Journal 61 (2010) 33e40values. With a core of trained radiologists and technologists,
it has been possible to continue offering a lower volume
service without additional funding.
However, a hospital is not the ideal site for a high-volume
outpatient service, especially for screening and surveillance.
A separate outpatient facility will enable less-expensive and
more-efficient provision of outpatient CTC, much as with
screening mammography. This will continue to help control
the waiting list for colonoscopy and allow the hospital CTC
service to concentrate on inpatients, symptomatic outpatients
in poorer health, and those who have had incomplete
colonoscopy.
Without funding, it is not feasible to run a service at the
volumes required to contribute to population screening and
keep colonoscopy wait lists at clinically appropriate levels
for symptomatic patients. There must be either an addition to
the global budget for the CT service, or a technical compo-
nent available to the hospital and outpatient clinic for each
patient who has a CTC examination. Activity-based funding
has worked in some circumstances [34,35] and may be
particularly appropriate to encourage the most cost-effective
delivery of an outpatient service like CTC.
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